Baker Brothers Advisors - AQUESTIVE THERAPEUTICS INC ownership

AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 49 filers reported holding AQUESTIVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 2.0%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of AQUESTIVE THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$317,000
-24.2%
99,6000.0%0.00%
-33.3%
Q2 2019$418,000
-39.2%
99,6000.0%0.00%
-25.0%
Q1 2019$688,000
+9.7%
99,6000.0%0.00%
-20.0%
Q4 2018$627,000
-64.0%
99,6000.0%0.01%
-54.5%
Q3 2018$1,744,00099,6000.01%
Other shareholders
AQUESTIVE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Bratton Capital Management, L.P. 9,810,958$16,188,081100.00%
Vahanian & Associates Financial Planning Inc. 725,208$1,196,5933.78%
Bracebridge Capital, LLC 428,571$707,1420.39%
Latash Investments, LLC 243,134$401,1710.32%
XTX Topco Ltd 138,145$227,9390.04%
ARMISTICE CAPITAL, LLC 1,158,000$1,910,7000.03%
OCCUDO QUANTITATIVE STRATEGIES LP 84,355$139,1860.01%
Hillsdale Investment Management Inc. 66,600$109,8900.01%
D.B. Root & Company, LLC 12,950$21,3680.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 147,856$243,9620.01%
View complete list of AQUESTIVE THERAPEUTICS INC shareholders